Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

Sonnet BioTherapeutics Holdings, Inc.

SONN · — · CIK 0001106838 · Healthcare

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines

Last qualifying purchase2023-10-27 · Rao Raghu · value unavailable

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

No Form 4 transaction event is present in the current 180-day window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-10-27 · Rao Raghu.

Recent Form 4 activity

0Purchases
0Sales
14Other Form 4 lines
9SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

The FINRA report lists no short interest for this ticker.

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2023-10-27Rao RaghuPurchase (P)Common Stock15,625USD —USD —SEC filing ↗
2023-10-27Mohan PankajPurchase (P)Common Stock34,375USD —USD —SEC filing ↗
2023-06-14Dexter SusanPurchase (P)Common Stock10,000USD 0.70USD 7,000SEC filing ↗
2023-05-30Dyrness Albert D.Purchase (P)Common Stock23,255USD 0.47USD 10,930SEC filing ↗
2023-05-17Bhatt NaileshPurchase (P)Common Stock25,000USD 0.23USD 5,750SEC filing ↗
2023-05-15Mohan PankajPurchase (P)Common Stock371,600USD 0.22USD 81,752SEC filing ↗
2023-03-15Mohan PankajPurchase (P)Common Stock60,000USD 0.59USD 35,400SEC filing ↗
2021-06-09Mohan PankajPurchase (P)Common Stock32,000USD 1.55USD 49,600SEC filing ↗
2021-06-09Kenney Richard TPurchase (P)Common Stock15,000USD 1.54USD 23,100SEC filing ↗
2021-05-19Kenney Richard TPurchase (P)Common Stock10,000USD 1.55USD 15,500SEC filing ↗
2020-06-11Dyrness Albert D.Purchase (P)Common Stock2,409USD 4.01USD 9,660SEC filing ↗
2020-06-10Mohan PankajPurchase (P)Common Stock2,400USD 4.09USD 9,816SEC filing ↗
2020-03-23Pruitt Michael DPurchase (P)Common Stock7,000USD 0.58USD 4,080SEC filing ↗
2020-03-23Glick Frederick LPurchase (P)Common Stock5,000USD 0.51USD 2,550SEC filing ↗
2020-01-31Pruitt Michael DPurchase (P)Common Stock206USD —USD —SEC filing ↗

Form 4 evidence

14 transaction lines in the latest 365-day window; 100 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2025-12-02Kenney Richard TOption exercise / conversion (M)Common Stock250,265USD —USD —SEC filing ↗
2025-12-02Kenney Richard TTax withholding (F)Common Stock16,891USD —USD —SEC filing ↗
2025-12-02Kenney Richard TD (D)Common Stock242,748USD —USD —SEC filing ↗
Show recent Form 4 evidence (11 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2025-12-02Kenney Richard TOption exercise / conversion (M)Common Stock250,265USD —USD —SEC filing ↗
2025-12-02Kenney Richard TTax withholding (F)Common Stock16,891USD —USD —SEC filing ↗
2025-12-02Kenney Richard TD (D)Common Stock242,748USD —USD —SEC filing ↗
2025-12-02Rao RaghuD (D)Common Stock22,356USD —USD —SEC filing ↗
2025-12-02McNeill LoriD (D)Common Stock4,394USD —USD —SEC filing ↗
2025-12-02MCANDREW STEPHEN JD (D)Common Stock6,446USD —USD —SEC filing ↗
2025-12-02Griffith Donald J.D (D)Common Stock10,375USD —USD —SEC filing ↗
2025-12-02Dyrness Albert D.D (D)Common Stock4,537USD —USD —SEC filing ↗
2025-12-02Dexter SusanD (D)Common Stock9,643USD —USD —SEC filing ↗
2025-12-02Cini John K.D (D)Common Stock14,116USD —USD —SEC filing ↗
2025-12-02Bhatt NaileshD (D)Common Stock10,547USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerSONN
CIK0001106838
SectorHealthcare
Industry— Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
Exchange—

Data coverage

Local Form 4 history100 transaction lines from 2020-01-31 to 2025-12-02
17 P purchase lines · 0 S sale lines · 83 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.